¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"spinal muscular atrophy, type III"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • parthenogenetic type
    ´Ü¼º»ý½ÄÇü
  • split-electrode-type probe
    ºÐÇÒÀü±Ø´õµëÀÚ
  • sthenic type
    ±Ù·ÂÇü
  • storage-type
    ÃàÀûÇü
  • swaged cast type crown
    ¾ÐÀÎÇü±Ý°ü
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü
  • simple type schizophrenia
    ´Ü¼øÇüÁ¤½ÅºÐ¿­º´
  • viral hepatitis type A
    AÇü¹ÙÀÌ·¯½º°£¿°
  • viral hepatitis type B
    BÇü¹ÙÀÌ·¯½º°£¿°
  • viral hepatitis type D
    DÇü¹ÙÀÌ·¯½º°£¿°
  • wild type
    ¾ß»ýÇü
  • wild type strain
    ¾ß»ýÁÖ
  • anterior spinal artery syndrome
    ¾Õô¼öµ¿¸ÆÁõÈıº
  • anterior spinal arthrodesis
    ¾ÕôÃßÀ¯ÇÕ¼ú, Àü¹æÃ´ÃßÀ¯ÇÕ¼ú
  • anterior spinal instrumentation
    ¾ÕôÃ߱ⱸ°íÁ¤¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • spinal nerve
    ô¼ö½Å°æ
  • spinal accessory nerve
    ô¼ö´õºÎ½Å°æ
  • spinal trigeminal nucleus
    ô¼ö»ïÂ÷½Å°æÇÙ
  • spinal vestibular nucleus
    ô¼ö¾È¶ãÇÙ
  • posterior spinal sclerosis
    µÚô¼ö°æÈ­Áõ
  • progressive spastic spinal paralysis
    ÁøÇà°æÁ÷ô¼ö¸¶ºñ
  • spasmodic spinal paralysis
    (¢¡spastic spinal paralysis) °æÁ÷ô¼ö¸¶ºñ
  • spastic spinal paralysis
    °æÁ÷ô¼ö¸¶ºñ
  • spinal evoked potential
    ô¼öÀ¯¹ßÀüÀ§
  • spinal radiculitis
    ô¼ö»Ñ¸®¿°
  • spinal reflex
    ô¼ö¹Ý»ç
  • spinal root
    ô¼ö»Ñ¸®
  • spinal nerve root
    ô¼ö½Å°æ»Ñ¸®
  • spinal
    ô¼ö-, ôÃß-
  • spinal segment
    ô¼öºÐÀý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • C-type particle
    CÇü ÀÔÀÚ (·¹Æ®·Î¹ÙÀÌ·¯½ºÀÇ)
  • C-type virus particle
    CÇü ¹ÙÀÌ·¯½ºÀÔÀÚ.
  • Charcot-Marie type
    »þ¸£ÄÚ-¸¶¸®Çü.
  • Duchenne-Landouzy type
    µÚ½Ã¿£´À-¶õµÎ¿ìÁöÇü.
  • Gougerot-Ruiter type vasculitis
    ±¸Á¦·Î ·çÀÌÅÍ Çü Ç÷°ü¿°
  • L-type chnnels
    L-Çü Åë·Î(÷×ÖØ)
  • Lafora body type of myoclonus
    ¶óÆ÷¶ó üÇü ¸¶ÀÌ¿ÀŬ·Î´©½º.
  • Lutheran s type
    ·çÅ×¶õÇü.
  • Mobitz type I SA block
    ¸ðºñÃ÷ ¥°Çü µ¿¹æÂ÷´Ü.
  • Mobitz type II AV block
    ¸ðºñÃ÷ ¥±Çü ¹æ½ÇÂ÷´Ü.
  • Mobitz type II SA block
    ¸ðºñÃ÷ ¥±Çü µ¿¹æÂ÷´Ü.
  • Ogawa type
    ¿À°¡¿ÍÇü
  • RF coil type
    °íÁÖÆÄ ÄÚÀÏ À¯Çü
  • T-type channel
    T-Çü Åë·Î
  • aberrant type
    ÀÌÇü(ì¶úþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • halisteretic atrophy
    Żȸ¼º À§Ãà(÷­üéàõê×õê).
  • hemilingual atrophy
    ÆíÃø¼³À§Ãà
  • hereditary optic atrophy
    À¯Àü¼º ½Ã½Å°æÀ§Ãà.
  • hereditary optic atrophy
    À¯Àü¼º½Ã½Å°æÀ§Ãà.
  • hypothenar atrophy
    ¼ÒÁö±¸ À§Ãà(á³ò¦Ï¹êÍõê).
  • hypothenar atrophy
    ¼ÒÁö±¸À§Ãà.
  • iris atrophy
    ȫäÀ§Ãà
  • ischemic optic atrophy
    ÇãÇ÷½Ã½Å°æÀ§Ãà
  • lactation atrophy
    ¼öÀ¯À§Ãà(¡­ê×õê).
  • lacunar optic atrophy
    ÇØ¸é½Ã½Å°æÀ§Ãà
  • leaping atrophy
    ºñ¿ùÀ§Ãà
  • lobar atrophy
    ³ú¿±À§Ãà(Òàç¨ê×õê).
  • macular atrophy
    ¹Ý»óÀ§Ãà(Áõ)(ÚèßÒê×õêñø)
  • mast atrophy
    À¯¼±À§Ãà(¡­ê×õê).
  • median white atrophy
    Á¤Áß ¹é»ö À§Ãà
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CONPA-DRI III conpa-dri I plus intensified doxorubicin
DSM-III-R Diagnostic and Statistical Manual of Mental Disorders [of APA], third edition, revised
III Roman numeral three
III-para tertipara
MS I, II, III, IV medical student-first, second, third, and fourth year
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
PDE III phosphodiesterase III
URO-III-S uroporphyrinogen III synthase
DMD Duchenne type muscular dystrophy
FCMD Fukuyama type congenital muscular dystrophy
PIIINP N-propeptide of type III procollagen
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • spinal dorsal horn
    ô¼ö ¹èÃø°¢
  • spinal dysraphism
    ôÃß Èıà ¹ÌºÀ, ôÃß Èıà ¹ÌºÀÁõ
  • spinal ganglion
    ô¼ö ½Å°æÀý
  • spinal input
    ô¼ö ÀÔ·Â
  • spinal laminar I
    ô¼ö ÆÇ I
  • spinal marrow
    ô¼ö
  • spinal musc of neck
    ¸ñ °¡½Ã±Ù, °æ±Ø±Ù
  • spinal muscle of head
    ¸Ó¸® °¡½Ã±Ù, µÎ±Ø±Ù
  • spinal nerve
    ô¼ö ½Å°æ
    ô¼ö¿Í º¹ºÎ, ÈäºÎ, »çÁö°£¿¡ ÀÓÆÞ½º¸¦ Àü´ÞÇÏ´Â ¸»ÃÊ ½Å°æ.
  • spinal nociceptive projection cell
    ô¼ö À¯ÇØ Åõ»ç ¼¼Æ÷
  • spinal nociceptive transmission
    ô¼ö À¯ÇØ Àü´Þ
  • spinal pain transmission
    ô¼ö µ¿Åë Àü´Þ
  • spinal pain transmission neuron
    ô¼ö µ¿Åë Àü´Þ ´º¿ì·±
  • spinal pathway
    ô¼ö °æ·Î
  • spinal reflex
    ô¼ö ¹Ý»ç
    ³ú¿Í ô¼ö »çÀ̸¦ Àý´ÜÇÑ ½ÇÇè µ¿¹°À» ô¼ö µ¿¹°À̶ó°í Çϸç, ÀÌ Ã´¼ö µ¿¹°¿¡¼­ º¼ ¼ö ÀÖ´Â ¹Ý»ç ±â´ÉÀ» ô¼ö ¹Ý»ç¶ó°í ÇÑ´Ù. ¿¹¸¦ µé¸é, ¿¡¼­ ³ú¿Í ô¼ö »çÀ̸¦ Àý´ÜÇÑ Ã´¼ö °³±¸¸®¿¡ ÃÊ»êÀ» ¹Ù¸¥ Á¾À̸¦ ´Ù¸®¿¡ ºÙÀ̸é ÀÚ±ØÀ» ¹Þ¾Æ ´Ù¸®¸¦ ¿òÃ÷¸°´Ù. ¿îµ¿°èÀÇ ¹Ý»ç·Î¼­´Â »çÁöÀÇ ±ÙÀ» ½ÅÀå½ÃŰ¸é ±× ±ÙÀÌ ¼öÃàÇÏ´Â ½ÅÀå ¹Ý»ç¿Í ÇǺθ¦ ÀÚ±ØÇßÀ» ¶§ »çÁö°¡ ¸öÅë ÂÊÀ¸·Î ±Á¾îÁö´Â ±¼±Ù ¹Ý»ç°¡ ÀÖ´Ù. ½ÅÀå ¹Ý»çÀÇ ¼ö¿ë±â´Â ±Ù ¼Ó¿¡ ÀÖ´Â ±Ù¹æÃßÀε¥, À̰ÍÀÌ ½ÅÀåµÇ¸é ±¸½É¼º Ãæ°ÝÀ» ÀÏÀ¸ÄÑ Ã´¼ö ÁßÃß¿¡¼­ ÀüȯµÇ¾î ¿îµ¿ ½Å°æ¿¡ Àü´ÞµÇ°í, °á±¹ ½ÅÀåµÇ¾ú´ø ±ÙÀÌ ¼öÃàÇÏ´Â ¹Ý»çÀÌ´Ù. ±ÙÀÌ ½ÅÀåµÇ¾î ±æ°Ô ´Ã¾î³ª¸é ¼öÃàÇÏ¿© ±× ±æÀ̸¦ ¿ø·¡´ë·Î µÇµ¹¸®´Â ÀÛ¿ëÀ» ÇÏ´Â °ÍÀ¸·Î¼­, ±ÙÀÇ ±æÀ̸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ´Â ¹Ý»ç¶ó°íµµ ÇÒ ¼ö ÀÖ´Ù. °üÀý Çϳª¿¡´Â ½Å±Ù°ú ±¼±ÙÀÌ Àִµ¥ µÑ ´Ù ½ÅÀå ¹Ý»ç°¡ ÀÖ¾î ±ÙÀÇ ±æÀ̸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇϱ⠶§¹®¿¡ °üÀýÀÌ °íÁ¤µÇ´Â °ÍÀÌ´Ù. ¹°·Ð ô¼ö µ¿¹°¿¡¼­´Â ¾ÆÁ÷ ½Å±Ù°ú ±¼±Ù°úÀÇ ½ÅÀå ¹Ý»ç¸¦ ÅëÇÕÇÒ ¼ö°¡ ¾øÀ¸¹Ç·Î ³ú°£ÀÇ ÅëÇÕ¿¡ ÀÇÇØ¼­¸¸ ºñ·Î¼Ò °üÀýÀÌ °íÁ¤µÇ°í ÀÚ¼¼¸¦ À¯ÁöÇÒ ¼ö ÀÖ°Ô µÈ´Ù. ±¼°î ¹Ý»ç´Â ÇǺηκÎÅÍÀÇ ±¸½É¼º Ãæ°ÝÀÌ Ã´¼öÀÇ ¹Ý»ç ÁßÃß¿¡¼­ »çÁöÀÇ ±¼±Ù¿¡ ÀÖ´Â ¿îµ¿ ½Å°æÀ¸·Î Àü´ÞµÇ´Â ¹Ý»çÀÌ´Ù. ¶ß°Å¿î °Í¿¡ ¼ÕÀÌ ´êÀ¸¸é ¹Ý»çÀûÀ¸·Î ±× ¼ÕÀ» ¿À¹Ç¸®´Â ÀÛ¿ëÀ» ÇÑ´Ù. ô¼ö¿¡´Â ÀÌ ¹Û¿¡µµ ÀÚÀ²½Å°æ ¹Ý»ç ÁßÃß°¡ ÀÖ´Ù. ¿¹ÄÁ´ë ¹è´¢ ÁßÃß, ¹èº¯ ÁßÃß¿Í ±× ¹Û¿¡ ºÒ¿ÏÀüÇÑ lÂ÷ ÁßÃ߷μ­ ¹ßÇÑ, Á¥ ºÐºñ, ½ÉÀå ¹Úµ¿ ÃËÁø, Ç÷°ü ¼öÃà µîÀ» ÀÏÀ¸Å²´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
marantic atrophy <medicine> A wasting of flesh without fever or apparent disease; a kind of consumption; atrophy; phthisis. "Pining atrophy, Marasmus, and wide-wasting pestilence." (Milton) Marasmus senilis [L], progressive atrophy of the aged.
Origin: NL, fr. Gr, fr, to quench, as fire; pass, to die away.
Source: Websters Dictionary
(01 Mar 1998)
red atrophy Atrophy due to destruction of the parenchymatous cells of an organ as a consequence of chronic venous congestion.
Synonym: red atrophy.
(05 Mar 2000)
gingival atrophy The exposure of root surface by an apical shift in the position of the gingiva.
(12 Dec 1998)
villous atrophy Abnormality of the small intestinal mucosa with crypt hyperplasia, resulting in flattening of the mucosa and the appearance of atrophy of villi; clinically seen in malabsorption syndromes such as sprue.
(05 Mar 2000)
central areolar choroidal atrophy A slowly progressive pigmentary degeneration in young persons; characterised by black foci closely set together and coalescent at the posterior pole and macular region.
Synonym: central areolar choroidal atrophy, central areolar choroidal sclerosis.
(05 Mar 2000)
pelvofemoral muscular dystrophy One of the less well-defined types of muscular dystrophy, probably heterogenous in nature. Onset usually in childhood or early adulthood and both sexes affected. Characterised by weakness and wasting, usually symmetrical, of the pelvic girdle muscles, the shoulder girdle muscles, or both, but not the facial muscles. Muscle pseudohypertrophy, heart involvement, and mental retardation are absent. Variable inheritance.
Synonym: Leyden-Mobius muscular dystrophy, pelvofemoral muscular dystrophy, scapulohumeral muscular dystrophy.
(05 Mar 2000)
Vulpian's atrophy Progressive spinal muscular atrophy beginning in the shoulder.
Synonym: scapulohumeral atrophy.
(05 Mar 2000)
cerebellar atrophy A degeneration of the cerebellum, particularly the Purkinje cells, as the result of abiotrophy or of toxic agents, as in alcoholism.
(05 Mar 2000)
periodontal atrophy Decrease in size and/or cellular elements of the periodontium after it has reached normal maturity.
(05 Mar 2000)
childhood muscular dystrophy The most common childhood muscular dystrophy, with onset usually before age 6. Characterised by symmetrical weakness and wasting of first the pelvic and crural muscles and then the pectoral and proximal upper extremity muscles; pseudohypertrophy of some muscles, especially the calf; heart involvement; sometimes mild mental retardation; progressive course and early death, usually in adolescence. X-linked inheritance (affects males and transmitted by females).
Synonym: childhood muscular dystrophy, Duchenne's disease, pseudohypertrophic muscular dystrophy.
(05 Mar 2000)
choroidal vascular atrophy Atrophy affecting either all choroidal vessels or only the choriocapillaris, occurring either diffusely or confined to the posterior pole of the eye.
(05 Mar 2000)
gyrate atrophy Progressive, autosomal recessive, diffuse atrophy of the choroid, pigment epithelium, and sensory retina that begins in childhood.
(12 Dec 1998)
gyrate atrophy of choroid and retina A slowly progressive atrophy of the choriocapillaris, pigmentary epithelium, and sensory retina, with irregular confluent atrophic areas and an associated ornithinuria; autosomal recessive inheritance; due to a deficiency of ornithine d-aminotransferase.
(05 Mar 2000)
circular layer of muscular coat The inner, circular layer of the smooth muscle of the muscular coat. Nomina Anatomica lists circular layers of muscular coats (stratum circulare tunicae muscularis...) of the following: 1) colon (... Coli ); 2) rectum (... Recti ); 3) small intestine (... Intestini tenuis ); 4) stomach (... Gastrici ).
Synonym: stratum circulare tunicae muscularis gastricae, stratum circulare tunicae.
(05 Mar 2000)
circular layers of muscular tunics The inner, circular layer of the smooth muscle of the muscular coat. Nomina Anatomica lists circular layers of muscular coats (stratum circulare tunicae muscularis...) of the following: 1) colon (... Coli ); 2) rectum (... Recti ); 3) small intestine (... Intestini tenuis ); 4) stomach (... Gastrici ).
Synonym: stratum circulare tunicae muscularis gastricae, stratum circulare tunicae.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á